Key result
The presence of late gadolinium enhancement on cardiac MRI was associated with a 4-fold increased risk of major ventricular arrhythmic events in nonischemic dilated cardiomyopathy.
Why the study?
Risk stratification based mainly on left ventricular ejection fraction impairment has limited performance in NIDCM, prompting evaluation of the prognostic value of LGE on long-term arrhythmic and mortality outcomes.
Does the presence of LGE on CMR predict adverse long-term arrhythmic and mortality outcomes in patients with nonischemic dilated cardiomyopathy?
Meta-Analysis (n=15,217)
Does the presence of LGE on CMR predict adverse long-term arrhythmic and mortality outcomes in patients with nonischemic dilated cardiomyopathy?
Answers are grounded in this paper and cite their sources.
The presence of LGE on CMR is a strong predictor of adverse long-term outcomes in patients with NIDCM, suggesting its utility in risk stratification for primary prophylactic ICD placement.
Risk stratification based mainly on the impairment of left ventricular ejection fraction has limited performance in patients with nonischemic dilated cardiomyopathy (NIDCM). Evidence is rapidly growing for the impact of myocardial scar identified by late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMR) on cardiovascular events. We aim to assess the prognostic value of LGE on long-term arrhythmic and mortality outcomes in patients with NIDCM. PubMed, Scopus, and Cochrane databases were searched from inception to January 21, 2022. Studies that included disease-specific subpopulations of NIDCM were excluded. Data were independently extracted and combined via random-effects meta-analysis using a generic inverse-variance strategy. Data from 60 studies comprising 15,217 patients were analyzed with a 3-year median follow-up. The presence of LGE was associated with major ventricular arrhythmic events (pooled OR: 3.99; 95% CI 3.08, 5.16), all-cause mortality (pooled OR: 2.14; 95% CI 1.81, 2.52), cardiovascular mortality (pooled OR 2.83; 95% CI 2.23, 3.60), and heart failure hospitalization (pooled OR: 2.53; 95% CI 1.78, 3.59). Real-world evidence suggests that the presence of LGE on CMR was a strong predictor of adverse long-term outcomes in patients with NIDCM. Scar assessment should be incorporated as a primary determinant in the patient selection criteria for primary prophylactic implantable cardioverter-defibrillator placement.
No takes yet. Share an insight, caveat, or question.
Theerasuwipakorn et al. (2023) conducted a meta-analysis in Nonischemic dilated cardiomyopathy (n=15,217). Presence of late gadolinium enhancement (LGE) on cardiac MRI vs. Absence of LGE was evaluated on Major ventricular arrhythmic events (OR 3.99, 95% CI 3.08, 5.16). The presence of late gadolinium enhancement on cardiac MRI was associated with a 4-fold increased risk of major ventricular arrhythmic events in nonischemic dilated cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: